TESARO Announces Participation in Three Investor Conferences

WALTHAM, Mass., Oct. 24, 2016 (GLOBE NEWSWIRE) — TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in three upcoming investor conferences. The three conferences are: 

  • The Credit Suisse 25th Annual Healthcare Conference at The Phoenician in Scottsdale, Arizona on Monday, November 7 and Tuesday, November 8. Lonnie Moulder, CEO of TESARO, and Mary Lynne Hedley, Ph.D., President and COO of TESARO, will present on November 8 at 8:30 AM MT and will also host meetings with investors. 
  • The Global Mizuho Investor Conference at The Omni Berkshire Place in New York, New York on Monday, November 14. Tim Pearson, EVP and CFO of TESARO, will participate in meetings with investors. 
  • The Raymond James Boston Fall Investors Conference at The State Room in Boston, Massachusetts on Tuesday, November 15. Tim Pearson, EVP and CFO of TESARO, will participate in meetings with investors. 

A live webcast of the presentation at the Credit Suisse conference will be available by visiting the Investors section of the TESARO website at www.tesarobio.com. An archived replay of this webcast will be available on the Company’s website for 14 days following the conference. 

About TESARO
TESARO is an oncology-focused biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer. For more information, visit www.tesarobio.com, and follow us on Twitter and LinkedIn.

CONTACT: For additional information, please contact:     
Jennifer Davis
1.781.325.1116
jdavis@tesarobio.com

Left Menu Icon
Right Menu Icon